COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)				1 Months Ended		6 Months Ended
	Mar. 10, 2021	Sep. 06, 2016	Jun. 05, 2016	Jan. 22, 2022	Dec. 31, 2021	Jun. 30, 2022	Jan. 22, 2020	Jul. 24, 2019
Escrow agent rate per share								$ 1.90
Consideration received								$ 885,144
Financing agreement amount					$ 1,000,000
Royalty percent			20.00%
Warrants							5,000,000
Warrants broken into four tranches							1,250,000
Strike price							$ 0.25
Shenghuo Medical, LLC [Member]
Payment receive descriptions			the right to receive payments equal to 2% of the Company’s future sales in the United States, up to an aggregate of $4.0 million
Shandong Yaohua Medical Instrument Corporation [Member]
Balance due for outstanding purchase order						$ 23,445
Shares exchange								12,147
Consulting Agreement [Member] | Mr. Blumberg
Terms of amendment to agreement	on September 26, 2021, 900,000 3-year warrants with an exercise price of $0.30 and 400,000 common stock shares; (2) on March 26, 2022, 900,000 3-year warrants with an exercise price of $0.40 and 400,000 common stock shares; (3) on September 26, 2022, 900,000 3-year warrants with an exercise price of $0.50 and 400,000 common stock shares; and (4) on March 26, 2023, 900,000 3-year warrants with an exercise price of $0.60 and 400,000 common stock shares	royalty initially equal to $0.10, and from and after October 2, 2016, equal to $0.20, for each disposable	the right to receive payments equal to 2% of the Company’s future sales in the United States, up to an aggregate of $4.0 million.		the consulting agreement was amended to clarify that $350,000 is not intended to be debt and will not be required to be repaid in cash. Additionally, issuance of the warrants is now predicated on the Company receiving funding receipts of $1,000,000
Description of exchange of subscription	on September 26, 2021, 900,000 3-year warrants with an exercise price of $0.30 and 400,000 common stock shares; (2) on March 26, 2022, 900,000 3-year warrants with an exercise price of $0.40 and 400,000 common stock shares; (3) on September 26, 2022, 900,000 3-year warrants with an exercise price of $0.50 and 400,000 common stock shares; and (4) on March 26, 2023, 900,000 3-year warrants with an exercise price of $0.60 and 400,000 common stock shares.
Subscription receivable	$ 350,000
Promotional Agreement [Member]
Consulting expenses						79,444
Fair vaue of warrants				$ 715,000
Unrecognized consulting expense						$ 0
Royalty Agreement [Member]
Royalty paid description		royalty initially equal to $0.10, and from and after October 2, 2016, equal to $0.20, for each disposable
Royalty consideration		$ 50,000